falsefalse

Evolving Adjuvant Treatments for HER2+ Early Breast Cancer - Episode 1

Prognosis and Survival Outcomes for HER2+ Early Breast Cancer

,

Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss clinical updates to the management of patients with HER2-positive early breast cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Prognosis and Survival Outcomes for HER2+ Early Breast Cancer
    EP. 2: Evolving and Current Standards of Care for HER2+ Early Breast Cancer
    EP. 3: AE Management With Neratinib in HER2+ Early Breast Cancer
    EP. 4: Unmet Needs in HER2+ Early Breast Cancer
    EP. 5: Clinical Benefits With Neratinib in HER2+ Early Breast Cancer
    EP. 6: Ongoing Research Efforts in HER2+ Early Breast Cancer

    Related Content:

    Cleveland ClinicUniversity of Illinois Cancer CenterBreast CancerHER2+ Breast Cancer
    ADCs Are Poised to Transform the Metastatic TNBC Treatment Arsenal
    Dr Tolaney on the Optimal Timing of ESR1 Testing in HR+ Breast Cancer
    Dr Gluz on Ongoing Evaluations of De-Escalated Neoadjuvant Therapy in HR+/HER2+ Breast Cancer
    x